Sheldon Tobe (@sheldon_tobe) header
Sheldon Tobe (@sheldon_tobe) profile picture

Hypertension and Nephrology, co-Chair C-CHANGE, ❤️🇨🇦, @Sunnybrook, @CHEP+

Joined July 2012
Photo by Sheldon Tobe (@sheldon_tobe)Photo by Sheldon Tobe (@sheldon_tobe)Photo by Sheldon Tobe (@sheldon_tobe)Photo by Sheldon Tobe (@sheldon_tobe)Photo by Sheldon Tobe (@sheldon_tobe)
What if more patients received proven kidney- and heart-protective therapies? Study in #ASNJASN suggests that combining RASi, SGLT2i, and GLP-1RA could prevent substantially more deaths than current practice, yet use of these medications remains remarkably low. kidney.pub/JASN1287
7
1
16
2,270
Sheldon Tobe retweeted
Evaluating the Long-Term Risk of #KidneyFailure in #IgAN Using a #Real-World Population-Level Cohort From Canada #VisualAbsract by @deniise_am kireports.org/article/S2468-…
3
14
1,101
Sheldon Tobe retweeted
Among patients with hypertension due to primary aldosteronism, reductions in blood pressure and the aldosterone-to-renin ratio persisted for 2 years after completion of an extended course of aldosterone synthase inhibition. Full study results: nej.md/4jXjULO #ScientificSessions26 | @AHAScience
3
46
3
174
22,091
Sheldon Tobe retweeted
Presented at #ScientificSessions26: In patients with type 2 diabetes and high cardiovascular risk, a systolic blood-pressure target below 120 mm Hg did not result in fewer major cardiovascular events than a target below 140 mm Hg. Full OPTIMAL-DIABETES trial results: nej.md/3UZYKCy @AHAScience
10
114
13
370
35,220
Efficacy of empagliflozin in heart failure with preserved ejection fraction according to the presence of echocardiographic features of diastolic dysfunction in the EMPEROR-Preserved trial Baseline detection of echocardiographic DD predicted improved clinical response to empagliflozin in a graded fashion, but the reasons cannot be reliably determined from this analysis @HFA_President @EJHFEiC @ehj_ed @hfcollaboratory @gcfmd @SJGreene_md @mvaduganathan academic.oup.com/eurjhf/adva…
20
68
2,742
Hydralazine-isosorbide dinitrate in chronic heart failure with reduced ejection fraction: the H-HeFT trial Hydralazine-isosorbide dinitrate did not change the incidence of the composite endpoint of heart failure events or death in patients with heart failure and LVEF ≤40%. @HFA_President @hfcollaboratory @gcfmd @MasriAhmadMD @gcfmd @SJGreene_md academic.oup.com/eurheartj/a…
2
20
59
2,514
Sheldon Tobe retweeted
Fantastic news !!!
2
1
8
668
Intermittent or Continuous Renal-Replacement Therapy in Acute Kidney Injury | New England Journal of Medicine. CRRT as initial dialysis has better outcomes for ventilated adults on inotrope infusion requiring renal-replacement therapy.
25
Sheldon Tobe retweeted
I’m on a quest with fellow physicians to help protect 100,000 Canadian kidneys from diabetic kidney disease. Today we can delay or prevent many cases of kidney failure that lead to dialysis, especially when high blood pressure and type 2 diabetes are treated together, not one at a time. Your family doctor can do this. Ask whether your kidneys have been checked with a urine albumin test and a blood test for kidney function. Keep blood pressure and diabetes as well controlled as you can, and ask whether the right combination of kidney-protective medicines is in place. That combination usually starts with an ACE inhibitor or an ARB, the blood-pressure pills that protect the kidney filter, and can also include an SGLT2 inhibitor, a GLP-1 medicine (Ozempic and others), and, if there is protein in the urine, a mineralocorticoid blocker such as finerenone (Kerendia). savingkidneys.ca #Saving100KKidneys #KidneyHealth #DiabetesCare
1
2
122
Sheldon Tobe retweeted
COMMENTARY: Evaluating Patients for Renal Denervation: A Pragmatic Approach ahajrnls.org/4zcxOyb
8
10
1,158
Sheldon Tobe retweeted
Lp(a) and CAD polygenic scores did not improve SMART score prediction of coronary events after ischemic stroke. ahajrnls.org/3UrlyuK
1
5
13
1,166
Sheldon Tobe retweeted
Original Article: Sibeprenlimab in IgA Nephropathy — Final Phase 3 Trial Analysis (VISIONARY trial) nej.md/4z3QsZg #KidneyWk | @ASNKidney
2
34
92
15,412
Sheldon Tobe retweeted
Sex differences in cardiovascular disease burden, risk factors, and disease spectrum in Europe: a global burden of disease 2023 analysis within the ESC Atlas framework. Read more in #EHJ academic.oup.com/eurheartj/a… @escardio @ESC_Journals
14
40
3,121
Adria realized that lifestyle choices at younger ages affect your health later in life. Adria can’t help thinking about the what-ifs, but uses that as motivation to live a healthier life. See Adria's message to all women and read more: bit.ly/4jAmcjR.
1
1
337
Sheldon Tobe retweeted
KDOQI Commentary on the 2025 AHA/ACC Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults bit.ly/4elHxda (FREE) @taraichang @jenniferlcluett @kramer_holly @MRrenaldoc @LAwdishu
2
30
1
83
3,687
Sheldon Tobe retweeted
Proud to have been part of this important collaboration. As mentioned back in August when the results were presented at ESC - it’s always important to consider the evidence base and nuance within each trial. Top line results don’t tell the whole story (see PIF-PAF) nor does one study mean we forget everything that came before it.
🔥 Beyond placebo! Does AF ablation really improve quality of life? Our meta-analysis of sham-controlled RCTs shows that with AF ablation: ✅ +13.5 AFEQT points ✅ 51% lower AF recurrence ✅ Benefit beyond active-treatment controls ....and this is with SHORT follow-up and an "active treatment" control! 📖 Kakarla et al. Heart Rhythm, 2026. bit.ly/4iDdvnL @Dr_Saikiran_K @Hidehiro_1986 @DrJasonAndrade @JonathanAriya @Mel_Gunawardene @nmarrouche @melissaemm1 @Elliott_AD @peterkistler3 #AtrialFibrillation #EP #CHRD @HRSonline @thecsanz @hrs_journal
6
30
3,039
Orthostatic hypotension was not associated with ACEi/ARBs, DHP CCBs, thiazide diuretics but was associated with alpha blockers, a concern when they are used in the elderly. This data comes from an ARIC study visit specifically assessing orthostatic hypotension. Mean age 83.7 years.
Excited to share our team's paper on antihypertensive medications on temporal OH patterns among older adults led by the brilliant Dr. Khan! academic.oup.com/ajh/advance… @amjhypertension
1
2
55
Join in recognizing Adeera Levin, MD, recipient of the John P. Peters Award, for contributions to kidney care, research, and patient advocacy. Read more in #ASNKidneyNews: kidney.pub/KN1810-07
9
1
35
2,325
Screening and Treatment Using a Risk-Based Approach With NT-proBNP Guidance in Diabetes Mellitus: The STRONG-DM Pilot Study Among adults with T2DM and high risk for developing HF, a virtual CKM prevention strategy was feasible and increased prescription rates of preventive therapies @JACCJournals @mvaduganathan @gcfmd @SJGreene_md @DrMarthaGulati jacc.org/doi/10.1016/j.jchf.…
10
19
722
Sheldon Tobe retweeted
🧵 Among high-risk patients undergoing elective major abdominal surgery, individualized #CardiacIndex-guided hemodynamic therapy targeting each patient’s preoperative resting cardiac index did not reduce a composite of acute kidney injury, acute myocardial injury, severe infectious complications, nonfatal cardiac arrest, or death within 7 postoperative days vs routine hemodynamic therapy. These findings do not support this strategy for routine intraoperative management in this surgical population. ja.ma/4kbqBK2
2
5
20
6,115